(MENAFNEditorial) Dalradian Resources Inc.: Dalradian announces warrant exercises Dalradian announces warrant exercises
TORONTO, ONTARIO -- (Marketwired - September 22, 2017) - Dalradian Resources Inc. (TSX:DNA /AIM:DALR) ("Dalradian" or the "Company") announces that a total of 2,669,125 of Dalradian's common share purchase warrants originally issued on 7 October 2015 (the "October Warrants") were exercised between 28 August 2017 and 20 September 2017 at a price of C$1.04, resulting in proceeds to the Company of C$2,775,890.
The shares issued upon exercise of the warrants were admitted for trading on the AIM market of the London Stock Exchange as part of the block admission announced on 23 September 2016. 76,000 of the 2,669,125 common shares issued pursuant to the exercise of October Warrants were included within the total number of common shares in issue that was stated in the Company's announcement of 30 August 2017.
Following the October Warrant exercises, the Company will have in issue 282,848,946 common shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
About Dalradian Resources Inc.
Dalradian Resources Inc. is a mineral exploration and development company that is focused on advancing its high-grade Curraghinalt Gold Project located in Northern Ireland, United Kingdom.
For more information:
Marla GaleVice President Communications+1 416 583
Grant Thornton UK LLP (Nominated Adviser)Philip Secrett / Richard Tonthat / Harrison Clarke+44 (0)20 7383 5100
Canaccord Genuity Limited (Broker)Henry Fitzgerald-O'Connor / Martin Davison+44 20 7523 8000
MENAFN2209201700703653ID1095890387
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.